Clinical Trials Logo

Clinical Trial Summary

The term idiopathic rhinitis (IR) is used in this study to describe a patient group with following characteristics: patients with complaints of nasal obstruction, sneezing and/or rhinorrhea for a period of over 1 year, which cannot be attributed to allergy, nasal or paranasal infection, anatomical disorders, pregnancy or lactation and/or systemic disorders. These patients are non-smokers and do not use medication affecting nasal function. They have no beneficial effect of intranasal steroid spray (INS) treatment.

The population incidence of IR is estimated to be as high as 10%. The pathophysiology of IR is largely unknown. Several hypotheses have been put forward. In general it is assumed that neurogenic mechanisms play an important role. Neuropeptides like CGRP, SP, NKA/B, NPY, NGF are released from afferent neurons in the nasal mucosa after activation by unspecific stimuli and can be responsible for the symptoms of IR.

For this group of IR-patients, there is until now only one treatment option: intranasal capsaicin application. Capsaicin, the pungent agent in hot pepper, is supposed to exert its' therapeutic effect via degeneration or desensitization effect on the afferent C-fibers.

The hypothesis is that nasal capsaicin treatment reduces neurogenic inflammation and reduces in that way nasal symptoms.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01223820
Study type Interventional
Source Universitaire Ziekenhuizen Leuven
Contact
Status Completed
Phase Phase 4
Start date January 2011
Completion date September 2011

See also
  Status Clinical Trial Phase
Completed NCT04226131 - MusculRA: The Effects of Rheumatoid Arthritis on Skeletal Muscle Biomechanics N/A
Recruiting NCT02572700 - Pain Mechanisms and Ultrasonographic Disease Activity in Psoriatic Arthritis
Recruiting NCT01888783 - Two Measures of Tactile Acuity in CRPS Type I Patients N/A
Recruiting NCT03741478 - Intranasal Insulin and Olanzapine Study in Healthy Volunteers Phase 1
Completed NCT02919774 - Pomaglumetad Effects on Glutamate Biomarkers Phase 1
Completed NCT01460394 - Normative Data of Brain Network Activation in Adolescents and Young Adults
Completed NCT00771940 - Peripheral Metabolic Effects of Ghrelin Phase 1
Recruiting NCT06068322 - Supramaximal High-Intensity Interval Training in People With and Without Chronic Obstructive Pulmonary Disease N/A
Active, not recruiting NCT02652195 - Deciphering the Role of Oxytocin in Motivation: an fMRI Study. Part II Phase 2
Recruiting NCT06270108 - The Role of Glutamatergic Function in the Pathophysiology of Treatment-resistant Schizophrenia Early Phase 1
Withdrawn NCT04320966 - Neurovascular Complications and White Matter Damage in Acquired Anemias
Recruiting NCT05046184 - Elucidating the Neurocircuitry of Irritability With High-Field Neuroimaging to Identify Novel Therapeutic Targets Phase 2
Completed NCT03134963 - Cerebral Haemodynamic Changes During Cognitive Testing: A fTCD Study
Completed NCT03081546 - Cross-Cultural Use of Performance-Based Functional Assessment in Alzheimer's Disease
Completed NCT04085094 - Gender Differences in Renal Functioning and Disease
Completed NCT03520543 - [11C]Yohimbine PET Study of alpha2-AR Phase 1
Recruiting NCT06098612 - PET Imaging Evaluation of [11C]SY08 Early Phase 1
Completed NCT02134951 - Biomarker Assessment of Glutamatergic Target Engagement Phase 4
Active, not recruiting NCT05056610 - Confocal Laser Endomicroscopy to Determine Influence of Food Antigens on Mucosal Integrity N/A
Recruiting NCT05656378 - A Repository to Study Host-Microbiome Interactions in Health and Disease